DKK677.5 15.5 2.3%
Last Trade - 12:44pm
| Market Cap | £1.35bn |
| Enterprise Value | £1.33bn |
| Revenue | £28.5m |
| Position in Universe | 279th / 1829 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 30th Jun | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 61.2 | 85.2 | 90.3 | 112.7 | 175.5 | 214.1 | +28.4% | ||||
| +666.1 | +31.9 | -28.6 | +145.7 | +128.9 | +30.1 | |||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Chemometec A/S is a Denmark-based company engaged in the development, manufacture and sale of analytical instruments used for quantitative analysis of cells in liquids. The Company’s activities are divided into three business areas: Instruments, which offers a range of NucleoCounter analytical instruments for counting mammalian, animal, yeast and sperm cells, as well as somatic cells in milk, among others; Consumables, which distributes disposable cassettes, solutions, reagents and slides; and Other, which is responsible for the partnership development in a number of research projects, among others. The Company’s analytical products are based on a technology, which combines fluorescence microscopy with digital imagery. Its customer portfolio comprises entities active primarily within pharmaceutical, food processing and agriculture industries. Furthermore, the Company is a parent of ChemoMetec USA Inc.
| Last Annual | June 30th, 2020 |
| Last Interim | December 31st, 2020 |
| Incorporated | April 2, 1997 |
| Public Since | December 18, 2006 |
| No. of Shareholders: | 8,968 |
| No. of Employees: | 121 |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Index | |
| Exchange | OMX Nordic Exchange - Copenhagen |
| Shares in Issue | 17,402,479 |
| Free Float | (0.0%) |
| Eligible for |
✓
ISAs
✓
SIPPs
|
| Address | Gydevang 43, ALLEROED, 3450, Denmark |
| Web | https://chemometec.com/ |
| Phone | + |
| Contact | () |
| Auditors | Deloitte Statsautoriseret Revisionspartnerselskab |
As of 12:44pm, shares in Chemometec A/S are trading at DKK677.5, giving the company a market capitalisation of £1.35bn. This share price information is delayed by 15 minutes.
Shares in Chemometec A/S are currently trading at DKK677.5 and the price has moved by 0.153k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Chemometec A/S price has moved by 91.46% over the past year.
There are no analysts currently covering Chemometec A/S.
Chemometec A/S is scheduled to issue upcoming financial results on the following dates:
The Chemometec A/S dividend yield is 0.23% based on the trailing twelve month period.
Last year, Chemometec A/S paid a total dividend of 1.5, and it currently has a trailing dividend yield of 0.23%. Looking ahead, Chemometec A/S has not announced an ex-dividend date yet.
Chemometec A/S has yet to annouce their ex-dividend date. The historic dividend yield on Chemometec A/S shares is currently 0.23%.
To buy shares in Chemometec A/S you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Chemometec A/S are currently trading at DKK677.5, giving the company a market capitalisation of £1.35bn.
Here are the trading details for Chemometec A/S:
Based on an overall assessment of its quality, value and momentum, Chemometec A/S is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We were not able to load any forecast data for Chemometec A/S.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Chemometec A/S. Over the past six months, the relative strength of its shares against the market has been 30.2%. At the current price of DKK677.5, shares in Chemometec A/S are trading at 41.48% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Chemometec A/S PE ratio based on its reported earnings over the past 12 months is 0.156k. The shares are currently trading at DKK677.5.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Chemometec A/S's management team is headed by:
Here are the top five shareholders of Chemometec A/S based on the size of their shareholding:
